PEPTIDE RECEPTOR RADIONUCLIDE THERAPY FOR METASTATIC MEDULLARY THYROID CARCINOMA: A WESTERN AUSTRALIAN EXPERIENCE

被引：0
|
作者：
Pugazhenthi, Kamali [1 ]
机构：
[1] Fiona Stanley Hosp, Murdoch, WA, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy
    Grossrubatscher, Erika
    Fanciulli, Giuseppe
    Pes, Luca
    Sesti, Franz
    Dolci, Carlotta
    de Cicco, Federica
    Colao, Annamaria
    Faggiano, Antongiulio
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 16
  • [2] Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls
    Carolien M. Beukhof
    Tessa Brabander
    Francien H. van Nederveen
    Marie-Louise F. van Velthuysen
    Yolanda B. de Rijke
    Leo J. Hofland
    Gaston J. H. Franssen
    Lideke A. C. Fröberg
    Boen L. R. Kam
    W. Edward Visser
    Wouter W. de Herder
    Robin P. Peeters
    BMC Cancer, 19
  • [3] Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls
    Beukhof, Carolien M.
    Brabander, Tessa
    van Nederveen, Francien H.
    van Velthuysen, Marie-Louise F.
    de Rijke, Yolanda B.
    Hofland, Leo J.
    Franssen, Gaston J. H.
    Froberg, Lideke A. C.
    Kam, Boen L. R.
    Visser, W. Edward
    de Herder, Wouter W.
    Peeters, Robin P.
    BMC CANCER, 2019, 19 (1)
  • [4] Is peptide receptor radionuclide therapy still a promising option for medullary thyroid carcinoma?
    de Andrade, Fernanda Accioly
    Bulzico, Daniel
    Corbo, Rossana
    Vaisman, Fernanda
    ENDOCRINE, 2025, 87 (03) : 943 - 950
  • [5] Metastatic Medullary Thyroid Cancer (MTC): Is There a Role for Peptide Receptor Radionuclide Therapy (PRRT)?
    Hayes, A. R.
    Crawford, A.
    Al Riyami, K.
    Tang, C.
    Wild, D.
    Khoo, B.
    Caplin, M.
    Nicolas, G.
    Grossman, A. B.
    NEUROENDOCRINOLOGY, 2019, 108 : 273 - 273
  • [6] Is There a Role for Peptide Receptor Radionuclide Therapy in Medullary Thyroid Cancer?
    Vaisman, Fernanda
    Rosado de Castro, Paulo Henrique
    Proenca Lobo Lopes, Flavia Paiva
    Kendler, Daniel Barretto
    Pessoa, Cencita H. N.
    Bulzico, Daniel Alves
    Leal, Douglas de Carvalho
    Vilhena, Bruno
    Vaisman, Mario
    Carneiro, Michel
    Corbo, Rossana
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (02) : 123 - 127
  • [7] Gallium-68 DOTATATE PET/CT and peptide receptor radionuclide therapy for patients with refractory/recurrence metastatic medullary carcinoma of thyroid
    Assadi, M.
    Dadgar, H.
    Rekabpour, S.
    Jafari, E.
    Ahmadzadehfar, H.
    Amini, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S698 - S698
  • [8] AN ALTERNATIVE THERAPY OPTION IN METASTATIC THYROID CANCER: PEPTIDE RECEPTOR RADIONUCLIDE THERAPY
    Cinkir, Havva Yesil
    Elboga, Umut
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2020, 83 (04): : 339 - 344
  • [9] Peptide receptor radionuclide therapy for metastatic paragangliomas
    Pinato, David J.
    Black, James R. M.
    Ramaswami, Ramya
    Tan, Tricia M.
    Adjogatse, Delali
    Sharma, Rohini
    MEDICAL ONCOLOGY, 2016, 33 (05)
  • [10] Peptide receptor radionuclide therapy for metastatic paragangliomas
    David J. Pinato
    James R. M. Black
    Ramya Ramaswami
    Tricia M. Tan
    Delali Adjogatse
    Rohini Sharma
    Medical Oncology, 2016, 33
12345